HiP-8

N/A

Report date: 2025/01/26 18:55:22

Base Information

Drug NameHiP-8
Drug Alias NameHGFR targeting theranostic (Kanazawa University/RIKEN/Tohoku University/Osaka University/University of Tokyo)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionHepatocyte growth factor receptor inhibitors
TargetsHepatocyte growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKanazawa University
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A